Subscribe
Osocimab for VTE Prevention After TKA, Changes in FDA Approval and Regulation of Pharmaceuticals, Neuropsych Testing of Older Clinicians Prior to Recredentialing, and more

JAMA Editor’s Summary

Osocimab for VTE Prevention After TKA, Changes in FDA Approval and Regulation of Pharmaceuticals, Neuropsych Testing of Older Clinicians Prior to Recredentialing, and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 14, 2020 issue
January 14, 2020
ADVERTISEMENT
Wise-Formerly Transferwise

Osocimab for VTE Prevention After TKA, Changes in FDA Approval and Regulation of Pharmaceuticals, Neuropsych Testing of Older Clinicians Prior to Recredentialing, and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 14, 2020 issue

ADVERTISEMENT
Wise-Formerly Transferwise

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Javier Lozano - Market-Creating Innovation for Diabetes Care an inspiring conversation with Javier Lozano, Founder and CEO of Clínicas del Azúcar, a growing chain of "one-stop shops" for diabetes care in Mexico.